Transform the Future of Biomanufacturing in Asia: Digital, Continuous, and AI-Driven

Master the transition to connected manufacturing across the full product lifecycle, redefining bioprocessing operations, efficiency and sustainability.

Your Blueprint for Bioprocessing Success in Asia

The biopharma industry in Asia is rapidly evolving, but challenges like regulatory complexity, scaling digital transformation, and achieving operational excellence remain. BPI APAC 2026 is designed to help you overcome these hurdles with actionable insights, proven strategies, and unparalleled networking opportunities.

Achieve End-to-End Bioprocessing Excellence

Master the complete bioprocessing value chain from upstream and downstream processing to formulation, purification, and scale-up
Explore proven strategies for optimizing yields, ensuring product quality, and overcoming manufacturing challenges across biologics, biosimilars, and advanced therapies
Learn how leading manufacturers are achieving operational excellence through process optimization and robust quality systems.

Harness Innovation & Technology Integration

Discover cutting-edge advancements in biologics development, novel modalities, and next-generation manufacturing platforms.
Gain insights into AI-driven decision-making, advanced analytics, and digital transformation strategies that are connecting data, enabling smarter monitoring, and delivering consistent manufacturing outcomes.
Understand how to leverage process analytical technology (PAT) and automation to enhance efficiency and compliance.

Build a Collaborative Bioprocessing Ecosystem

Connect with industry peers, technology partners, and potential collaborators to exchange ideas and build strategic relationships.
Engage with APAC's biotech ecosystem to drive innovation and prepare for the future of biomanufacturing.
Meet with technology providers, CDMOs, and industry leaders to drive innovation and operational excellence across APAC.